Cresco Labs Inc.
CL
CNSX
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -2.04% | -0.73% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -2.04% | -0.73% | |||
| Cost of Revenue | -8.56% | 6.45% | |||
| Gross Profit | 4.99% | -7.45% | |||
| SG&A Expenses | 12.89% | -4.28% | |||
| Depreciation & Amortization | -11.89% | 27.51% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -0.75% | 2.85% | |||
| Operating Income | -11.23% | -20.52% | |||
| Income Before Tax | -762.76% | -468.11% | |||
| Income Tax Expenses | -84.82% | -28.67% | |||
| Earnings from Continuing Operations | -304.90% | -58.12% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -72.30% | 301.31% | |||
| Net Income | -413.59% | -4.41% | |||
| EBIT | -11.23% | -20.52% | |||
| EBITDA | -13.21% | -12.09% | |||
| EPS Basic | -407.08% | -4.12% | |||
| Normalized Basic EPS | -46.03% | 103.23% | |||
| EPS Diluted | -407.08% | -4.12% | |||
| Normalized Diluted EPS | -46.03% | 103.23% | |||
| Average Basic Shares Outstanding | 1.22% | 0.33% | |||
| Average Diluted Shares Outstanding | 1.22% | 0.33% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||